Douglas K. Owens, MD
Articles
September 30th 2013
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
Douglas K. Owens, MD Wade Aubry, MD Roy Beck, MD Joshua Benner, MD Jan E. Berger, PharmD Michael E. Chernew, PhD Felicia Forma, BSc Dana P. Goldman, PhD William H. Herman, MD Rebecca Killion, MA Darius Lakdawalla, PhD Anne L Peters, MD
July 2nd 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
February 12th 2013
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 1st 2024 | Updated: November 21st 2024
Table Multiple Myeloma Trials November 2024
